179 related articles for article (PubMed ID: 18570971)
1. Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IX.
Tang Y; Le LP; Matthews QL; Han T; Wu H; Curiel DT
Virology; 2008 Aug; 377(2):391-400. PubMed ID: 18570971
[TBL] [Abstract][Full Text] [Related]
2. Bovine adenovirus type 3 containing heterologous protein in the C-terminus of minor capsid protein IX.
Zakhartchouk A; Connors W; van Kessel A; Tikoo SK
Virology; 2004 Mar; 320(2):291-300. PubMed ID: 15016551
[TBL] [Abstract][Full Text] [Related]
3. Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion.
Li J; Le L; Sibley DA; Mathis JM; Curiel DT
Virology; 2005 Aug; 338(2):247-58. PubMed ID: 15996701
[TBL] [Abstract][Full Text] [Related]
4. Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.
Dmitriev IP; Kashentseva EA; Curiel DT
J Virol; 2002 Jul; 76(14):6893-9. PubMed ID: 12072490
[TBL] [Abstract][Full Text] [Related]
5. Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon.
Kurachi S; Koizumi N; Sakurai F; Kawabata K; Sakurai H; Nakagawa S; Hayakawa T; Mizuguchi H
Gene Ther; 2007 Feb; 14(3):266-74. PubMed ID: 17006548
[TBL] [Abstract][Full Text] [Related]
6. Fusion of Large Polypeptides to Human Adenovirus Type 5 Capsid Protein IX Can Compromise Virion Stability and DNA Packaging Capacity.
Poulin KL; McFall ER; Chan G; Provost NB; Christou C; Smith AC; Parks RJ
J Virol; 2020 Aug; 94(17):. PubMed ID: 32522855
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus protein IX: a new look at an old protein.
Parks RJ
Mol Ther; 2005 Jan; 11(1):19-25. PubMed ID: 15585402
[TBL] [Abstract][Full Text] [Related]
8. Derivation of a triple mosaic adenovirus for cancer gene therapy.
Tang Y; Wu H; Ugai H; Matthews QL; Curiel DT
PLoS One; 2009 Dec; 4(12):e8526. PubMed ID: 20046872
[TBL] [Abstract][Full Text] [Related]
9. A system for efficient generation of adenovirus protein IX-producing helper cell lines.
Vellinga J; Uil TG; de Vrij J; Rabelink MJ; Lindholm L; Hoeben RC
J Gene Med; 2006 Feb; 8(2):147-54. PubMed ID: 16288495
[TBL] [Abstract][Full Text] [Related]
10. Addition of a short peptide ligand to the adenovirus fiber protein.
Michael SI; Hong JS; Curiel DT; Engler JA
Gene Ther; 1995 Nov; 2(9):660-8. PubMed ID: 8548556
[TBL] [Abstract][Full Text] [Related]
11. Modification of pIX or hexon based on fiberless Ad vectors is not effective for targeted Ad vectors.
Kurachi S; Koizumi N; Tashiro K; Sakurai H; Sakurai F; Kawabata K; Nakagawa S; Mizuguchi H
J Control Release; 2008 Apr; 127(1):88-95. PubMed ID: 18258327
[TBL] [Abstract][Full Text] [Related]
12. Use of adenovirus protein IX (pIX) to display large polypeptides on the virion--generation of fluorescent virus through the incorporation of pIX-GFP.
Meulenbroek RA; Sargent KL; Lunde J; Jasmin BJ; Parks RJ
Mol Ther; 2004 Apr; 9(4):617-24. PubMed ID: 15093192
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus targeting to HLA-A1/MAGE-A1-positive tumor cells by fusing a single-chain T-cell receptor with minor capsid protein IX.
de Vrij J; Uil TG; van den Hengel SK; Cramer SJ; Koppers-Lalic D; Verweij MC; Wiertz EJ; Vellinga J; Willemsen RA; Hoeben RC
Gene Ther; 2008 Jul; 15(13):978-89. PubMed ID: 18323790
[TBL] [Abstract][Full Text] [Related]
14. Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector.
Campos SK; Parrott MB; Barry MA
Mol Ther; 2004 Jun; 9(6):942-54. PubMed ID: 15194061
[TBL] [Abstract][Full Text] [Related]
15. Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion.
Matthews QL; Sibley DA; Wu H; Li J; Stoff-Khalili MA; Waehler R; Mathis JM; Curiel DT
Mol Imaging; 2006; 5(4):510-9. PubMed ID: 17150163
[TBL] [Abstract][Full Text] [Related]
16. Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon.
Rux JJ; Burnett RM
Mol Ther; 2000 Jan; 1(1):18-30. PubMed ID: 10933908
[TBL] [Abstract][Full Text] [Related]
17. In vitro dynamic visualization analysis of fluorescently labeled minor capsid protein IX and core protein V by simultaneous detection.
Ugai H; Wang M; Le LP; Matthews DA; Yamamoto M; Curiel DT
J Mol Biol; 2010 Jan; 395(1):55-78. PubMed ID: 19853616
[TBL] [Abstract][Full Text] [Related]
18. Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting.
Campos SK; Barry MA
Virology; 2006 Jun; 349(2):453-62. PubMed ID: 16504233
[TBL] [Abstract][Full Text] [Related]
19. Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector.
Myhre S; Henning P; Granio O; Tylö AS; Nygren PA; Olofsson S; Boulanger P; Lindholm L; Hong SS
Gene Ther; 2007 Feb; 14(4):376-81. PubMed ID: 17036056
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization.
Rosa-Calatrava M; Grave L; Puvion-Dutilleul F; Chatton B; Kedinger C
J Virol; 2001 Aug; 75(15):7131-41. PubMed ID: 11435594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
